We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

209 hedge funds and large institutions have $1.08B invested in Adaptive Biotechnologies in 2022 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 88 increasing their positions, 58 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more call options, than puts

Call options by funds: $1.62M | Put options by funds: $417K

52% more repeat investments, than reductions

Existing positions increased: 88 | Existing positions reduced: 58

5.66% more ownership

Funds ownership: 88.71% → 94.37% (+5.7%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 221 → 209 (-12)

25% less first-time investments, than exits

New positions opened: 30 | Existing positions closed: 40

38% less capital invested

Capital invested by funds: $1.74B → $1.08B (-$657M)

Holders
209
Holders Change
-12
Holders Change %
-5.43%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
30
Increased
88
Reduced
58
Closed
40
Calls
$1.62M
Puts
$417K
Net Calls
+$1.21M
Net Calls Change
+$2.11M

Top Buyers

1
BWLSA
Blue Water Life Science Advisors
California
+$27.4M
2
BlackRock
BlackRock
New York
+$26.9M
3
AIM
ARK Investment Management
Florida
+$9.35M
4
Federated Hermes
Federated Hermes
Pennsylvania
+$7.4M
5
Principal Financial Group
Principal Financial Group
Iowa
+$6.02M

Top Sellers

1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$17.9M
2
CC
Casdin Capital
New York
-$13.9M
3
TCM
TimesSquare Capital Management
New York
-$10.9M
4
Ameriprise
Ameriprise
Minnesota
-$9M
5
TM
Tiger Management
New York
-$8.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS AM
76
UBS AM
Illinois
$861K -$574K -65,243 -38%
Susquehanna International Group
77
Susquehanna International Group
Pennsylvania
$833K +$296K +33,697 +49%
Invesco
78
Invesco
Georgia
$764K -$451K -51,305 -35%
PCM
79
Prelude Capital Management
New York
$762K -$448K -50,957 -35%
SO
80
STRS Ohio
Ohio
$759K +$826K +93,900 New
MFS
81
Mirabella Financial Services
United Kingdom
$746K +$811K +92,230 New
TD Asset Management
82
TD Asset Management
Ontario, Canada
$737K – – –
CS
83
Credit Suisse
Switzerland
$732K +$23.9K +2,720 +3%
EWM
84
Edge Wealth Management
New York
$728K – – –
AQR Capital Management
85
AQR Capital Management
Connecticut
$688K -$663K -75,420 -46%
Cerity Partners
86
Cerity Partners
New York
$656K +$28.3K +3,223 +4%
Macquarie Group
87
Macquarie Group
Australia
$631K -$3.09K -351 -0.4%
New York State Common Retirement Fund
88
New York State Common Retirement Fund
New York
$627K -$296K -33,710 -30%
William Blair & Company
89
William Blair & Company
Illinois
$596K -$684K -77,760 -51%
Barclays
90
Barclays
United Kingdom
$596K +$310K +35,276 +92%
RRCM
91
Rappaport Reiches Capital Management
Illinois
$551K – – –
LFP
92
Leeward Financial Partners
Washington
$543K -$12.4K -1,407 -2%
ACM
93
AlphaCrest Capital Management
New York
$534K +$174K +19,811 +43%
Qube Research & Technologies (QRT)
94
Qube Research & Technologies (QRT)
United Kingdom
$512K +$85K +9,669 +18%
PP
95
PDT Partners
New York
$485K -$3.16K -359 -0.6%
CA
96
Crewe Advisors
Utah
$484K +$5.39K +613 +1%
DekaBank Deutsche Girozentrale
97
DekaBank Deutsche Girozentrale
Germany
$480K – – –
MIM
98
MetLife Investment Management
New Jersey
$471K +$455K +51,756 +795%
P8IP
99
Pier 88 Investment Partners
California
$447K +$296K +33,660 +156%
Osaic Holdings
100
Osaic Holdings
Arizona
$446K +$41.1K +4,671 +9%
2 3
4
5 6

ADPT Hedge Fund Activity: Q2 2022 in Review

209 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q2 2022, worth a combined $1.08B — down 38% from $1.74B a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of ADPT and 30 opened new positions — a net loss of 10 holders — while 58 trimmed existing stakes and 88 added.

The largest buyer was Blue Water Life Science Advisors, opening a new position worth an estimated $27.4M. The largest seller was Massachusetts Financial Services, cutting an estimated $17.9M.

  • 209 institutional investors held Adaptive Biotechnologies (ADPT) as of Q2 2022, down from 221 in Q1 2022.
  • Funds reported $1.08B of Adaptive Biotechnologies stock for Q2 2022, down 38% quarter-over-quarter.
  • 30 funds opened new Adaptive Biotechnologies positions in Q2 2022 and 40 closed out, a net change of -10 holders.
  • The largest Adaptive Biotechnologies buyer in Q2 2022 was Blue Water Life Science Advisors, an estimated $27.4M added.
  • The largest Adaptive Biotechnologies seller in Q2 2022 was Massachusetts Financial Services, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2022.